These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 9890427)

  • 1. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraspousal transmission of GB virus C/hepatitis G virus in an hepatitis C virus hyperendemic area in Japan.
    Akiyoshi F; Sata M; Noguchi S; Suzuki H; Ide T; Uchimura Y; Sasaki M; Tanaka K; Miyajima I; Mizokami M; Tanikawa K
    Am J Gastroenterol; 1999 Jun; 94(6):1627-31. PubMed ID: 10364035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.
    Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T
    Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
    Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
    J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
    Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
    Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
    Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
    Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance].
    Sarrazin C; Roth WK; Zeuzem S
    Z Gastroenterol; 1998 Nov; 36(11):997-1008. PubMed ID: 9880826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.
    Sauleda S; Reesink HJ; Esteban JI; Hess G; Esteban R; Guardia J
    J Med Virol; 1999 Sep; 59(1):45-51. PubMed ID: 10440807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.
    Tillmann HL; Heringlake S; Trautwein C; Meissner D; Nashan B; Schlitt HJ; Kratochvil J; Hunt J; Qiu X; Lou SC; Pichlmayr R; Manns MP
    Hepatology; 1998 Aug; 28(2):379-84. PubMed ID: 9696000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze River, China.
    Cao K; Mizokami M; Orito E; Ding X; Ueda R; Chen G; Yu SZ; Tokudome S
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1241-8. PubMed ID: 9918433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
    Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
    Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
    J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interspousal transmission of GB virus-C/hepatitis G virus: a comparison with hepatitis C virus.
    Kao JH; Liu CJ; Chen PJ; Chen W; Hsiang SC; Lai MY; Chen DS
    J Med Virol; 1997 Dec; 53(4):348-53. PubMed ID: 9407382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A; Doerr HW; Scharrer I; Weber B
    J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
    Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban JI; Tanaka E; Kiyosawa K; Alter HJ; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel AM
    Hepatology; 1997 Dec; 26(6):1626-33. PubMed ID: 9398008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model.
    Hassoba HM; Pessoa MG; Terrault NA; Lewis NJ; Hayden M; Hunt JC; Qiu X; Lou SC; Wright TL
    J Med Virol; 1998 Nov; 56(3):253-8. PubMed ID: 9783694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplant.
    Elkayam O; Hassoba HM; Ferrell LD; Garcia-Kennedy R; Gish RG; Wright TL; Laffler T; Traylor D; Hunt G; Rosenthal P
    Pediatr Res; 1999 Jun; 45(6):795-8. PubMed ID: 10367767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.